ATC Group: J01FA10 Azithromycin

Position of J01FA10 in the ATC hierarchy

Level	Code	Title
1	J	Antiinfectives for systemic use
2	J01	Antibacterials for systemic use
3	J01F	Macrolides, lincosamides and streptogramins
4	J01FA	Macrolides
5	J01FA10	Azithromycin

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	0.3 g
PAREN	Parenteral	0.5 g

Active ingredients in J01FA10

Active Ingredient
Azithromycin
Azithromycin is a macrolide antibiotic belonging to the azalide group. The molecule is constructed by adding a nitrogen atom to the lactone ring of erythromycin A. The mechanism of action of azithromycin is based upon the suppression of bacterial protein synthesis by means of binding to the ribosomal 50S sub-unit and inhibition of peptide translocation.

Related product monographs

Document	Type	Information Source
AZIMAX Tablet	MPI, US: SPL/PLR	Web Search
ZEDBAC Powder for solution for infusion	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
ZITHROMAX Capsule, hard	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
ZITHROMAX Film-coated tablet / Powder for suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)
ZITHROMAX Powder for solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicines in this ATC group

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.